Speaker Profile
Glenn S. Tillotson

Glenn S. Tillotson PhD, FRSM, FCCP

Infectious Disease
Chapel Hill, North Carolina, United States of America

Connect with the speaker?

Dr. Tillotson, Ph.D., FRSM, FCCP has 30+ years pharmaceutical experience in early pre-clinical and clinical research, commercialization, medical affairs, scientific communications including publication planning strategic drug development, life cycle management and global launch programs. Dr Tillotson has been instrumental in the development and launch of ciprofloxacin, moxifloxacin, gemifloxacin and other antibacterials. Glenn has held several key committee positions at the American College of Chest Physicians, he is on the Scientific Steering Committee for the GTCBio. Annual Summit on Anti-infective Partnering. Currently Dr. Tillotson has published >140 peer-reviewed manuscripts, presented >270 scientific posters and is on several journal Editorial Advisory Boards including the Lancet Infectious Disease
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)